452 related articles for article (PubMed ID: 33280949)
1. Comparative study of mucinous and non-mucinous appendiceal neoplasms with peritoneal dissemination treated by cyoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Garach NR; Kusamura S; Guaglio M; Bartolini V; Deraco M; Baratti D
Eur J Surg Oncol; 2021 May; 47(5):1132-1139. PubMed ID: 33280949
[TBL] [Abstract][Full Text] [Related]
2. Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin.
Munoz-Zuluaga CA; King MC; Ledakis P; Gushchin V; Sittig M; Nieroda C; Zambrano-Vera K; Sardi A
Eur J Surg Oncol; 2019 Sep; 45(9):1598-1606. PubMed ID: 31109821
[TBL] [Abstract][Full Text] [Related]
3. Outcomes in Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
Zambrano-Vera K; Sardi A; Munoz-Zuluaga C; Studeman K; Nieroda C; Sittig M; King MC; Sipok A; Gushchin V
Ann Surg Oncol; 2020 Jan; 27(1):179-187. PubMed ID: 31646450
[TBL] [Abstract][Full Text] [Related]
4. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
[TBL] [Abstract][Full Text] [Related]
5. Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA).
Milovanov V; Sardi A; Ledakis P; Aydin N; Nieroda C; Sittig M; Nunez M; Gushchin V
Eur J Surg Oncol; 2015 May; 41(5):707-12. PubMed ID: 25633641
[TBL] [Abstract][Full Text] [Related]
6. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: an emerging treatment option for advanced goblet cell tumors of the appendix.
McConnell YJ; Mack LA; Gui X; Carr NJ; Sideris L; Temple WJ; Dubé P; Chandrakumaran K; Moran BJ; Cecil TD
Ann Surg Oncol; 2014 Jun; 21(6):1975-82. PubMed ID: 24398544
[TBL] [Abstract][Full Text] [Related]
7. Validation of the Recent PSOGI Pathological Classification of Pseudomyxoma Peritonei in a Single-Center Series of 265 Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Baratti D; Kusamura S; Milione M; Bruno F; Guaglio M; Deraco M
Ann Surg Oncol; 2018 Feb; 25(2):404-413. PubMed ID: 29159742
[TBL] [Abstract][Full Text] [Related]
8. Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience.
Feferman Y; Solomon D; Bhagwandin S; Kim J; Aycart SN; Feingold D; Sarpel U; Labow DM
Ann Surg Oncol; 2019 Feb; 26(2):482-489. PubMed ID: 30539491
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Molecular Classification of Appendiceal Mucinous Neoplasms Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Su J; Jin G; Votanopoulos KI; Craddock L; Shen P; Chou JW; Qasem S; O'Neill SS; Perry KC; Miller LD; Levine EA
Ann Surg Oncol; 2020 May; 27(5):1439-1447. PubMed ID: 31980985
[TBL] [Abstract][Full Text] [Related]
10. Ki67 does not predict recurrence for low-grade appendiceal mucinous neoplasms with peritoneal dissemination after cytoreductive surgery and HIPEC.
Ward EP; Okamuro L; Khan S; Hosseini M; Valasek MA; Ronquillo N; Kelly KJ; Veerapong J; Lowy AM; Baumgartner J
Hum Pathol; 2021 Jul; 113():104-110. PubMed ID: 33905776
[TBL] [Abstract][Full Text] [Related]
11. Surveillance of Low-Grade Appendiceal Mucinous Neoplasms With Peritoneal Metastases After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Are 5 Years Enough? A Multisite Experience.
Solomon D; Bekhor E; Leigh N; Maniar YM; Totin L; Hofstedt M; Aycart SN; Carr J; Ballentine S; Magge DR; Golas BJ; Pai RK; Polydorides AD; Bartlett DL; Labow DM; Choudry HA; Sarpel U
Ann Surg Oncol; 2020 Jan; 27(1):147-153. PubMed ID: 31385130
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological analysis of appendiceal goblet cell adenocarcinoma with peritoneal metastasis: World Health Organization grade predicts survival following cytoreductive surgery with intraperitoneal chemotherapy.
Shyu S; Choudry H; Hall L; Pingpank J; Holtzman M; Bartlett D; Pai RK
Histopathology; 2020 Nov; 77(5):798-809. PubMed ID: 32557796
[TBL] [Abstract][Full Text] [Related]
13. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for perforated low-grade appendiceal mucinous neoplasms.
Abudeeb H; Selvasekar CR; O'Dwyer ST; Chakrabarty B; Malcolmson L; Renehan AG; Wilson MS; Aziz O
Surg Endosc; 2020 Dec; 34(12):5516-5521. PubMed ID: 31993814
[TBL] [Abstract][Full Text] [Related]
14. Misdiagnosis of appendiceal neoplasms as ovarian tumors: Impact of prior gynecologic surgery on definitive cytoreduction and HIPEC.
Garland-Kledzik M; Maithel S; Jafari MD; Dehkordi-Vakil F; Chaudhry H; Dinicu A; Chang I; Krasnoff C; Gambhir S; Sheehan B; Pigazzi A
Eur J Surg Oncol; 2022 Feb; 48(2):449-454. PubMed ID: 34454813
[TBL] [Abstract][Full Text] [Related]
15. Histologic Predictors of Recurrence in Mucinous Appendiceal Tumors with Peritoneal Dissemination after HIPEC.
Reghunathan M; Kelly KJ; Valasek MA; Lowy AM; Baumgartner JM
Ann Surg Oncol; 2018 Mar; 25(3):702-708. PubMed ID: 29282599
[TBL] [Abstract][Full Text] [Related]
16. Systemic metastases from low-grade and high-grade pseudomyxoma peritonei: Treatments and outcomes.
Baratti D; Milito P; Kusamura S; Martin Roman L; Guaglio M; Deraco M
Eur J Surg Oncol; 2022 Jul; 48(7):1590-1597. PubMed ID: 35090796
[TBL] [Abstract][Full Text] [Related]
17. Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus Surgery Without HIPEC for Goblet-Cell Carcinoids and Mixed Adenoneuroendocrine Carcinomas: Propensity Score-Matched Analysis of Centers in the Netherlands and Belgium.
Sluiter NR; van der Bilt JD; Croll DMR; Vriens MR; de Hingh IHJT; Hemmer P; Aalbers AGJ; Bremers AJA; Ceelen W; D'Hoore A; Schoonmade LJ; Coupé V; Verheul H; Kazemier G; Tuynman JB;
Clin Colorectal Cancer; 2020 Sep; 19(3):e87-e99. PubMed ID: 32651131
[TBL] [Abstract][Full Text] [Related]
18. An International Registry of Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Mercier F; Passot G; Bonnot PE; Cashin P; Ceelen W; Decullier E; Villeneuve L; Walter T; Levine EA; Glehen O; ;
World J Surg; 2022 Jun; 46(6):1336-1343. PubMed ID: 35286418
[TBL] [Abstract][Full Text] [Related]
19. The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery.
Kusamura S; Barretta F; Yonemura Y; Sugarbaker PH; Moran BJ; Levine EA; Goere D; Baratti D; Nizri E; Morris DL; Glehen O; Sardi A; Barrios P; Quénet F; Villeneuve L; Gómez-Portilla A; de Hingh I; Ceelen W; Pelz JOW; Piso P; González-Moreno S; Van Der Speeten K; Deraco M;
JAMA Surg; 2021 Mar; 156(3):e206363. PubMed ID: 33502455
[TBL] [Abstract][Full Text] [Related]
20. Hyperthermic Intraperitoneal Chemotherapy Following Cytoreductive Surgery Improves Outcome in Patients With Primary Appendiceal Mucinous Adenocarcinoma: A Pooled Analysis From Three Tertiary Care Centers.
Shaib WL; Martin LK; Choi M; Chen Z; Krishna K; Kim S; Brutcher E; Staley C; Maithel SK; Philip P; Abdel-Misih S; Bekaii-Saab TS; El-Rayes BF
Oncologist; 2015 Aug; 20(8):907-14. PubMed ID: 26070916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
